|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1523 News |
|
| «12...1011121314151617181920...3031» |
- Fluarix (influenza virus trivalent vaccine) / GSK
Trial initiation date: Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya (clinicaltrials.gov) - Apr 7, 2014
P2/3, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
Initiation date: Jan 2014 --> Apr 2014
- Fluarix (influenza virus trivalent vaccine) / GSK
Enrollment change: Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya (clinicaltrials.gov) - Apr 7, 2014
P2/3, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
Initiation date: Jan 2014 --> Apr 2014 N=720 --> 0
- |||||||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
New P3 trial: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (clinicaltrials.gov) - Apr 6, 2014
P3, N=540, Recruiting, Sponsor: Novartis
- ||||||| Trial completion: H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older (clinicaltrials.gov) - Apr 6, 2014
P3, N=91, Completed, Sponsor: Baxter Healthcare Corporation
N=720 --> 0 Active, not recruiting --> Completed
- | New P4 trial: Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients (clinicaltrials.gov) - Apr 2, 2014
P4, N=195, Not yet recruiting, Sponsor: Butantan Institute
- ||||| Enrollment closed: Japanese Pediatric H5N1 Vaccine Study (clinicaltrials.gov) - Apr 2, 2014
P3, N=60, Active, not recruiting, Sponsor: Baxter Healthcare Corporation
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment open: Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects (clinicaltrials.gov) - Apr 2, 2014
P1, N=48, Recruiting, Sponsor: Autoimmune Technologies, LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Trial completion: Vitamin B12 Supplementation During Pregnancy (clinicaltrials.gov) - Apr 1, 2014
P2/3, N=120, Completed, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- || Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
New P3 trial: Intradermal Influenza Vaccine in the Young (clinicaltrials.gov) - Apr 1, 2014
P3, N=160, Recruiting, Sponsor: The University of Hong Kong
- | New P4 trial: Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group. (clinicaltrials.gov) - Mar 31, 2014
P4, N=220, Recruiting, Sponsor: Mahidol University
- | New P2 trial: Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations (clinicaltrials.gov) - Mar 30, 2014
P2, N=400, Not yet recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- ||||| Fluarix Quadrivalent (influenza vaccine) / GSK
Enrollment change: An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children (clinicaltrials.gov) - Mar 26, 2014
P3, N=12000, Recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed N=8200 --> 12000
- Clinical: Arm Pump in Motorcross Training (clinicaltrials.gov) - Mar 24, 2014
P=N/A, N=40, Not yet recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
- Trial suspension: Microbiology of Otitis Media in Costarrican Children After PCV13 Introduction (clinicaltrials.gov) - Mar 23, 2014
P=N/A, N=387, Suspended, Sponsor: Instituto de Atención Pediátrica
N=8200 --> 12000 Not yet recruiting --> Suspended
- Trial completion: Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine (clinicaltrials.gov) - Mar 23, 2014
P1, N=40, Completed, Sponsor: PATH
Not yet recruiting --> Suspended Recruiting --> Completed
- |||||||||| Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi
New P3 trial: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants (clinicaltrials.gov) - Mar 20, 2014
P3, N=458, Recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
- |||||||||| New P2/3 trial: Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study) (clinicaltrials.gov) - Mar 18, 2014
P2/3, N=405, Not yet recruiting, Sponsor: PT Bio Farma
- |||||||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
New P3 trial: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions (clinicaltrials.gov) - Mar 17, 2014
P3, N=540, Recruiting, Sponsor: Novartis Vaccines
- |||| Panblok (influenza vaccine) / Sanofi
Trial completion: Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (clinicaltrials.gov) - Mar 17, 2014
P1/2, N=341, Completed, Sponsor: Protein Sciences Corporation
Recruiting --> Completed Active, not recruiting --> Completed
- | Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial completion, Combination therapy: Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) (clinicaltrials.gov) - Mar 17, 2014
P3, N=284, Completed, Sponsor: Sanofi Pasteur MSD
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging (clinicaltrials.gov) - Mar 15, 2014
P=N/A, N=165, Recruiting, Sponsor: Columbia University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Agriflu (trivalent influenza virus vaccine) / CSL Behring, FLUAD (trivalent inactivated influenza vaccine) / CSL Behring, Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial completion: Comparison of 4 Influenza Vaccines in Seniors (clinicaltrials.gov) - Mar 13, 2014
P4, N=953, Completed, Sponsor: University of British Columbia
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Fluzone (influenza vaccine) / Sanofi
Enrollment closed: Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) - Mar 9, 2014
P4, N=40, Active, not recruiting, Sponsor: Johns Hopkins Bloomberg School of Public Health
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Fluzone (influenza vaccine) / Sanofi
Trial completion: CMI: Cell Mediated Immunity in Older Adults (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=105, Completed, Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||| MenHibrix (GSK 792014) / GSK
Enrollment open: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix (clinicaltrials.gov) - Mar 5, 2014
P3, N=600, Recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| New P1/2 trial: A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1 (clinicaltrials.gov) - Mar 3, 2014
P1/2, N=610, Recruiting, Sponsor: Novavax
- ||| Trial completion: RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly (clinicaltrials.gov) - Mar 3, 2014
P1, N=220, Completed, Sponsor: Novavax
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- CR-8020 / AIM Therap
Trial withdrawal: Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection (clinicaltrials.gov) - Mar 2, 2014
P2, N=0, Withdrawn, Sponsor: Crucell Holland BV
Active, not recruiting --> Completed Suspended --> Withdrawn
- CR-8020 / AIM Therap
Enrollment change: Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection (clinicaltrials.gov) - Mar 2, 2014
P2, N=0, Withdrawn, Sponsor: Crucell Holland BV
Suspended --> Withdrawn N=262 --> 0
- | CR-8020 / AIM Therap
Trial completion: Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge (clinicaltrials.gov) - Mar 2, 2014
P2a, N=22, Completed, Sponsor: Crucell Holland BV
N=262 --> 0 Recruiting --> Completed
- ||| VGX-3500 / GeneOne
Trial completion: A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus (clinicaltrials.gov) - Feb 27, 2014
P1, N=116, Completed, Sponsor: Inovio Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- ||| New P3 trial: Phase III Study of Intramuscular TAK-816 in Healthy Infants (clinicaltrials.gov) - Feb 26, 2014
P3, N=30, Recruiting, Sponsor: Takeda
- Enrollment closed: Brief Influenza Vaccine Education to Pregnant Women (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=184, Active, not recruiting, Sponsor: The University of Hong Kong
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=280, Completed, Sponsor: Group Health Cooperative
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || Enrollment closed: Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older. (clinicaltrials.gov) - Feb 24, 2014
P1, N=600, Active, not recruiting, Sponsor: Novartis Vaccines
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| New P1/2 trial: Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge (clinicaltrials.gov) - Feb 23, 2014
P1/2, N=110, Recruiting, Sponsor: Immune Targeting Systems Ltd
- ||| Enrollment closed: A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model (clinicaltrials.gov) - Feb 23, 2014
P2, N=101, Active, not recruiting, Sponsor: Genentech
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Trial completion: A/H5N1in Adult - Aventis (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=452, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting No longer recruiting --> Completed
- ||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=63061, Completed, Sponsor: MedImmune LLC
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV) (clinicaltrials.gov) - Feb 22, 2014
P2, N=52, Completed, Sponsor: MedImmune LLC
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Fluarix (influenza virus trivalent vaccine) / GSK
Trial completion: Fluarix Immunogenicity and Safety Trial (clinicaltrials.gov) - Feb 22, 2014
P3, N=1050, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- ||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P3, N=300, Completed, Sponsor: MedImmune LLC
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Immunotherapy of Melanoma Patients (clinicaltrials.gov) - Feb 22, 2014
P1, N=9, Completed, Sponsor: Centre Hospitalier Universitaire Vaudois
No longer recruiting --> Completed Recruiting --> Completed
- | FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion: Safety Study to Evaluate FluMist in Immunocompromised Children (clinicaltrials.gov) - Feb 22, 2014
P1, N=20, Completed, Sponsor: MedImmune LLC
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Immune Response to Influenza Vaccine in HIV-Infected Individuals (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=165, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs (clinicaltrials.gov) - Feb 22, 2014
P1, N=18, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Pneumococcal vaccines: Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 (clinicaltrials.gov) - Feb 22, 2014
P2, N=620, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Half-Dose Flu Vaccine Study in Healthy Adults (clinicaltrials.gov) - Feb 19, 2014
P2, N=840, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||||||| Trial completion: Study of a Flu Vaccine in Children (clinicaltrials.gov) - Feb 19, 2014
P3, N=15000, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed No longer recruiting --> Completed